Health in Code’s foundational mission is the identification of health problems that may benefit from a genetic diagnosis, and the development and provision of genetic testing services for those conditions.

Since the beginning of the company, our main differential value is the combination of Knowledge Management tools with an expert dedicated multidisciplinary team, which allows us to provide a unique level of interpretation for the best genotyping.

Health in Code (HIC) is a biotechnological company with an international vocation that arises after years of clinical and research experience. The company was founded in 2006 as a spin-off from the University of A Coruna, Spain.

Currently HIC is specialized in high quality sequencing services and in the interpretation of genetic tests, providing clinicians with the tool to offer personalized medical care.

HIC is the European leader on genetic diagnosis of inherited cardiovascular diseases and constantly extending its scope to other diseases: dyslipidemias, skeletal myopathies and most recently, cancer.